Document:

Exhibit 10.22

EXHIBIT 10.22    Cigna Corporation — Cigna Long-Term Incentive Plan: Restricted Stock Grant Agreement 

Cigna Corporation (“Cigna”) has granted you the number of shares of restricted stock of Cigna set forth below in this Restricted Stock Grant Agreement (“Restricted Stock Grant” or “Grant”) under the Cigna Long-Term Incentive Plan (“Plan”). The award is subject to the provisions of the Plan and the Terms and Conditions below. 

You should carefully read all the terms and conditions of this Restricted Stock Grant and be sure you understand what they say and what your responsibilities and obligations are before you click on the ACCEPT button to acknowledge and agree to this Grant. 

If you are not willing to agree to all of the Grant terms and conditions, do not accept the Grant and do not click the ACCEPT button for the Restricted Stock Grant Acknowledgment and Agreement. If you do not accept the Grant, you will not receive the benefits of the Grant. 

If you do click on the ACCEPT button, you are accepting and agreeing to all of the terms and conditions of this Restricted Stock Grant. 

Participant: Sally X. Sample 

Global ID: 000XXXXXX 

Award Type: Restricted Stock 

Plan Name: Cigna Long-Term Incentive Plan 

Award Date: __-__-____

Award Expiration Date: N/A 

Total Granted: X,XXX.0000

Award Price: $0.0000 (USD) 

Vesting Schedule 

	

Shares/Options Awarded

	

Vest Date

	

XX.XXXX

	

__-__-____

	

XX.XXXX

	

__-__-____

	

XX.XXXX

	

__-__-____

You should also read the Key Contacts and Reference Materials document attached to your grant by clicking the REVIEW button. The Key Contacts and Reference Materials document contains information on how to get important stock award information (such as the Plan document, Plan Prospectus, Tax Considerations and Cigna’s Securities Transactions and Insider Trading Policy) and whom to contact if you have questions. 

Please be aware that the Cigna Securities Transactions and Insider Trading Policy places restrictions on your transactions in Cigna securities and requires certain Cigna employees to obtain advance permission from the Corporate Secretary before executing transactions in Cigna securities. 

If you have questions about your award, please contact the Cigna Shareholder Services by email at shareholderservices@cigna.com or by phone at 215.761.3516. 

Important Notice: Restricted Stock Grant Acknowledgment and Agreement 

By clicking on the ACCEPT button, I: 

1.

	Acknowledge and represent to Cigna that I have: 

a.

	received the Restricted Stock Grant; 

b.

	read and understand its terms and conditions, which include, among other things, restrictive covenants such as non-competition, customer and employee non-solicitation and non-disclosure provisions and a litigation cooperation provision; and 

c.

	received answers to any questions I had about the Grant and its terms and conditions, including the restrictive covenants. 

2.

	Understand and agree that: 

a.

	Pennsylvania law governs the interpretation and construction of the Grant; and 

b.

	any controversy or proceeding arising out of or relating to the restrictive covenants in the Grant will be brought exclusively before a federal or state court in the Commonwealth of Pennsylvania where venue is appropriate and that has subject matter jurisdiction (collectively, “Pennsylvania Courts”). 

3.

	Consent to Pennsylvania Courts exercising personal jurisdiction over me in any dispute about the restrictive covenants. 

Scroll down for the TERMS AND CONDITIONS of the Restricted Stock Grant. 

1

TERMS AND CONDITIONS OF ______ ____ GRANTS OF RESTRICTED STOCK     

These Terms and Conditions are an important part of your _____ __, ____ grant of Restricted Stock from Cigna Corporation (Cigna). The terms of your Restricted Stock grant are in: (a) the electronic Restricted Stock Grant Agreement, (b) these Terms and Conditions, and (c) the applicable Plan provisions. 

Certain words in this document with first letters capitalized are defined in the Restricted Stock Grant Agreement, these Terms and Conditions or Article 2 of the Plan. This grant is void if you are not an employee of Cigna or a Subsidiary (a Cigna company) on _____ __, ____.

1.	Restricted Stock; Restrictions 

Shares of Restricted Stock (Shares) are regular shares of Cigna Common Stock, but they are subject to certain Restrictions. The Restrictions are: 

(a)

	You cannot sell or transfer the Shares to anyone during the Restricted Period; and 

(b)

	Unless an exception applies, you will forfeit (lose your right to) the Shares if you have a Termination of Employment during the Restricted Period. 

Article 7 of the Plan describes these Restrictions in more detail. In addition, you must also comply with all the other terms and conditions of this grant, including those contained in this document. 

2.	Restricted Period; Vesting 

The Restricted Period starts on ______ __, ____ and ends on the Vesting Date. The Restrictions on the Shares will end (your Shares will vest) on the Vesting Date only if you remain continuously employed by a Cigna company from the grant date to the Vesting Date and comply with all the terms and conditions of this grant, including those contained in this document. 

You have three separate Vesting Dates under this grant because the Shares will vest in three stages: [50%] on _____ __, ____; an [additional 25%] on ____ __, ____; and the [remaining 25%] on _____ __, ____. Your Vesting Date may be earlier (see paragraph 3). 

3.	Early Vesting 

In certain situations your Vesting Date may be earlier than the Vesting Dates listed under paragraph 2: 

(a)

	The Shares will vest upon your Termination of Employment if it is Upon a Change of Control (of Cigna Corporation) or due to your death or Disability. 

(b)

	The Shares may vest upon your Termination of Employment if: 

(1)

	It is due to your Early Retirement or Retirement; and 

(2)

	The People Resources Committee or its designee (including Cigna’s senior human resources officer) approves the early vesting before your Termination of Employment. 

If you want to be considered for early vesting when you retire, you must ask your manager or human resources representative far enough in advance of your retirement so there is time to process your request. 

4.	Voting Rights; Dividends 

(a)

	You have the right to vote the Shares. If you forfeit a Share, you will also forfeit the right to vote the Share. 

(b)

	You have the right to receive dividends on the Shares. Dividends paid on the Shares during the Restricted Period will be held by Cigna. Subject to the forfeiture provisions of paragraph 4(c), your right to receive accumulated dividends on a Share will vest on the scheduled Vesting Date for the Share described in paragraph 2 (Scheduled Vesting Date). Once a Share vests, your right to future dividends on the Share, and the method of payment, will be the same as for any other Cigna shareholder. 

(c)

	If you forfeit a Share, you will also forfeit the right to any accumulated and future dividends related to the Share. Even if you do not forfeit a Share, you will forfeit the right to any accumulated dividends on the Share if: 

(1)

	You have a Termination of Employment before the Scheduled Vesting Date for a Share (even if the Share vests under paragraph 3); 

(2)

	The Scheduled Vesting Date for a Share occurs before the Share vests (because vesting is delayed); or 

(3)

	You are on a leave of absence when the Share vests. 

(d)

	Vested accumulated dividends, less applicable taxes withheld, will be paid to you in a lump sum within 70 days after the Scheduled Vesting Date. Cigna will not pay any interest on the accumulated dividends. 

2

5.	Taxes at Vesting 

When the Shares vest, you must satisfy any required tax withholding obligation. Cigna reserves the right to withhold enough newly-vested Shares to cover all or part of any applicable tax withholding. However, if section 83(b) of the U.S. Internal Revenue Code of 1986, as amended, applies to you and you make a timely election under that provision, you must make an immediate cash payment to satisfy any required tax withholding obligation. 

6.	Book-Entry Shares; Sale of Shares 

(a)

	Cigna (or a custodian appointed by Cigna) will hold your Shares before and after vesting in book-entry form in your Stock Account. That is, a record of your Share ownership will be kept electronically, and you will not risk losing any Share certificates. A certificate for vested Shares will be issued to you only if you ask for one, but not if you have engaged in a Violation (described in paragraph 7(b)). 

(b)

	You may generally sell or transfer vested Shares at any time, but your right to sell the Shares after they vest may be limited by Cigna. This right is subject to the terms of Cigna’s Securities Transactions and Insider Trading Policy, and Cigna reserves the right, for any reason at any time, to suspend or delay action on any request you make to sell the Shares. 

7.	Conditions of Grant 

(a)

	By accepting the grant, you are agreeing not to engage in any Violation described in paragraph 7(b). You understand and agree that your agreement not to engage in any Violation is a material part of the inducement for Cigna’s granting you the Shares and an essential pre-condition to your eligibility to exercise any rights associated with the Shares and retain any benefit from the vesting of the Shares. 

(b)

	You will engage in a “Violation” if, directly or indirectly, you engage in any misconduct described in subparagraph (1) below or you break any of the “Promises” in paragraphs 7(b)(2) through (6) below: 

(1)

Misconduct:

(A)

	You have a Termination of Employment initiated by a Cigna company because of your misconduct, as that term is defined in Cigna’s Code of Ethics, Standards of Conduct or other employment policies. 

(B)

	You do anything else while an employee of any Cigna company that is not discovered by the company until after your Termination of Employment and that would, if you had still been employed at the time of the discovery, be reason for your Termination of Employment for misconduct, as described above. 

(2)

Promise Not To Compete against Cigna Companies:

The Promise in this paragraph 7(b)(2) will remain in effect after your Termination of Employment only if you resign for any reason or a Cigna company terminates your employment for your misconduct, as described in paragraph 7(b)(1)(A). The Promise will remain in effect, for example, if your Termination of Employment is due to the elimination of your job. 

(A)

	If you are in Career Band 6 or higher on your Termination of Employment date: 

You Promise not to become employed by, work as a consultant or independent contractor for, or in any way render services or assistance to any Cigna Competitor (defined in paragraph 7(b)(2)(C) below) at any time during the period that starts on the grant date and ends 12 months after your Termination of Employment. 

You acknowledge and agree that: 

(i)

	Cigna’s business competes on a global basis; 

(ii)

	Cigna’s sales and marketing plans are for continued expansion throughout the United States of America and globally; 

(iii)

	You have had access to and received Confidential Information (described in paragraph 7(b)(5)(B) below); and 

(iv)

	The time restrictions and global nature of this non-competition restriction are reasonable and necessary to protect Cigna’s business and Confidential Information. 

(B)

	If you are in Career Band 5 or below on your Termination of Employment date: 

You Promise not to become employed by, work as a consultant or independent contractor for, or in any way render services or assistance to any Cigna Competitor (defined in paragraph 7(b)(2)(C) below) at any time during the period that starts on the grant date and ends 12 months after your Termination of Employment, if that work is similar to, and within the same geographic area as, the work you performed, or for which you had responsibility, at any Cigna company at any time during the six-month period that ends on your Termination of Employment date. 

3

For example: 

(i)

	If you are a sales employee and your sales territory at any time during your last six months of Cigna company employment is Pennsylvania, New Jersey, and New York, this paragraph 7(b)(2)(B) would apply to you only if you work in a sales position for a Cigna Competitor and only to the extent your new sales territory is Pennsylvania, New Jersey, and/or New York; 

(ii)

	If you are an underwriter with nationwide responsibilities at any time during your last six months of Cigna company employment, and you seek a job with a Cigna Competitor as an underwriter, the restrictions in paragraph 7(b)(2)(B) would be nationwide in scope; or 

(iii)

	If you work in a particular division or segment of Cigna, you would not be permitted to work in a similar division or segment for a Cigna Competitor where the work you are expected to perform for the competitor is similar to the work you performed for any Cigna company. 

You acknowledge and agree that you have had access to and received Confidential Information (described in paragraph 7(b)(5)(B) below) and the above time and geographic restrictions are reasonable and necessary to protect Cigna’s business and Confidential Information. 

(C)

	“Cigna Competitor” means any business that competes directly or indirectly with any Cigna company’s product or service. 

(3)

Promise Not To Solicit or Hire Cigna Company Employees:

(A)

	You Promise that, at any time during your Cigna company employment and the period that ends 12 months after your Termination of Employment, you will not: 

(i)

	Solicit any employee of any Cigna company to terminate his/her employment with, or otherwise cease his/her relationship, contractual or otherwise, with that Cigna company; or 

(ii)

	Hire any Cigna company employee. 

(B)

	This paragraph 7(b)(3) will not apply to applications for employment submitted voluntarily by any Cigna employee, in response to a general advertisement or otherwise, so long as neither you, nor anyone acting on your behalf or in response to information provided by you, otherwise Solicits the employees to leave Cigna. 

(C)

	To “Solicit” means to entice, encourage, persuade, or solicit, or to attempt to entice, encourage, persuade or solicit. 

(4)

Promise Not To Solicit Cigna Company Customers:

(A)

	You Promise that, at any time during your Cigna company employment and the period that ends 12 months after your Termination of Employment, you will not: 

(i)

	Solicit any Cigna company customer to end an existing relationship, contractual or otherwise, with that Cigna company; 

(ii)

	Solicit any Cigna company customer to reduce the volume of their business dealings with Cigna; or 

(iii)

	Solicit any potential Cigna company customer to enter into any business arrangements with you or any business which you may become employed by, or affiliated in any way with, after leaving any Cigna company, if such business arrangements would compete in any way with any business that Cigna company has conducted, or has been planning to conduct, during the 12-month period ending on the date of the Violation. 

(B)

	The Promise in paragraph 7(b)(4)(A) above applies only to a customer or potential customer with whom you had any Material Contact while employed by any Cigna company. “Material Contact” means you: 

(i)

	Had business dealings with the customer on behalf of any Cigna company within the three-year period ending on the date of the Solicitation; 

(ii)

	Were responsible for supervising or coordinating the dealings between any Cigna company and the customer or potential customer anytime during the three-year period ending on the date of the Solicitation; or 

(iii)

	Obtained, at any time, trade secrets or confidential information about a customer or potential customer with whom you had contact as a result of your employment by any Cigna company. 

(C)

	“Solicit” is defined in paragraph 7(b)(3)(C). 

(5)

Promise Not To Disclose Cigna Companies’ Confidential Information:

(A)

	You Promise not to disclose any Confidential Information to any third-party at any time, whether during or after your employment, without the prior written consent of Cigna (except to the extent required by an order of a court having competent jurisdiction or a properly issued subpoena) unless that Confidential Information was previously disclosed publicly by Cigna or has become public knowledge (other than by your disclosure). 

(B)

	“Confidential Information” means any Cigna company trade secrets, confidential information, or proprietary materials, including but not limited to customer lists, financial records, marketing plans and sales plans. 

4

(6)

Promise to Cooperate With Cigna in Investigations or Litigation:

(A)

	You Promise that, at any time after your Termination of Employment, you will cooperate with Cigna in (i) all investigations of any kind, (ii) helping to prepare and review documents and meeting with Cigna attorneys, and (iii) providing truthful testimony as a witness or a declarant during discovery and/or trial in connection with any present or future court, administrative, agency, or arbitration proceeding involving any Cigna company and with respect to which you have relevant information. 

(B)

	Cigna agrees that it will reimburse you, upon production of appropriate receipts and in accordance with Cigna’s then existing Business Travel Reimbursement Policy, the reasonable business expenses (including air transportation, hotel, and similar expenses) incurred by you in connection with such assistance. You must present to Cigna for reimbursement all receipts for those expenses within 45 days after you incur the expenses. 

(c)

	(1)	If you were an Executive Officer at any time during the 24-month period before the date of the Violation, the People Resources Committee will determine whether you engaged in a Violation and will have the sole discretion to waive your obligation to make all or any part of the Payment (described in paragraph 8) and to impose conditions on any waiver. 

(2)

	Otherwise, Cigna’s Senior Human Resources Officer, or his or her designee, will determine whether you engaged in a Violation and will have the sole discretion to waive your obligation to make all or any part of the Payment and to impose conditions on any waiver. 

(3)

	Determinations of the People Resources Committee, Cigna’s Senior Human Resources Officer, or his or her designee, will be final and binding on all parties. 

8.	Consequences of a Violation: Payment to Cigna 

Important: This paragraph 8 is not Cigna’s only remedy for a Violation. Cigna may seek any additional legal or equitable remedy, including an injunction described in paragraph 9, for a Violation. 

(a)

	You will immediately forfeit all unvested Shares if you engage in any Violation at any time. 

(b)

	You must immediately make the Payment described in paragraph 8(c) to Cigna in the manner described in paragraph 8(d) if: 

(1)

	You engage in a Violation described in paragraph 7(b)(2) (compete against Cigna), 7(b)(3) (Solicit or hire Cigna employees) or 7(b)(4) (Solicit Cigna customers), either while you are a Cigna company employee or within 12 months after your Termination of Employment; or 

(2)

	You engage in a Violation described in paragraph 7(b)(1) (misconduct), 7(b)(5) (disclose Confidential Information) or 7(b)(6) (fail to cooperate) at any time.

(c)

	“Payment” is the value you realize from any Shares that vest during the 12-month period ending on the date of the Violation. The Payment will equal: 

(1)

	The number of Shares that vest during that 12-month period; 

multiplied by 

(2)

	The Fair Market Value of those Shares on their Vesting Date; 

plus 

(3)

	The total amount of all dividends, if any, paid to you on those Shares through the date of the Payment. 

(d)

	Cigna will recover the Payment from you by any means permitted by applicable law, at the sole discretion of Cigna management, including but not limited to any or all of the following methods: 

(1)

	If you have any Shares in your Stock Account or in any other account in book-entry form when a Violation occurs, Cigna will take back from you the whole number of Shares that has a total Fair Market Value as of the date of the Violation up to, but not more than, the Payment amount. 

(2)

	Cigna will, to the extent permitted by applicable law, reduce: 

(A)

	The amount of any payments that any Cigna company owes you for any reason (including without limit any payments owed to you under any nonqualified retirement, deferred compensation or other plan or arrangement) by 

(B)

	The Payment amount. 

This reduction will not occur until the date a future payment to you is due. 

(3)

	Cigna will send you a written notice and demand for all or part of any Payment amount. Within 30 days after you receive that notice and demand, you must make the Payment to Cigna. 

5

9.	Consequences of a Violation: Injunction 

You agree that: 

(a)

	Cigna will be entitled to ask a court of competent jurisdiction to issue an order (an injunction) that requires you to take action and/or that prohibits you from taking action, as needed to ensure that you keep all of the Promises described in paragraph 7(b)(2) through (6), and Cigna will not be required to post a bond in order to seek or obtain the injunction; 

(b)

	Any breach or threatened breach of any of the Promises would cause irreparable injury to Cigna, and monetary damages alone would not provide an adequate remedy; and

(c)

	The remedies described in paragraph 9(a) are in addition to any other rights and remedies Cigna may have at law or in equity. 

10.	Agreeing to Assume Risks 

Cigna and its transfer agent will try to process your stock transaction requests in a timely manner; however, Cigna makes no promises or guarantees to you relating to the market price of the Shares or to the time it may take to act on your request to sell the Shares or deliver stock certificates. By accepting this Restricted Stock grant: 

(a)

	You acknowledge that the action you request may not be completed until several days (or in the case of delivery of stock certificates, several weeks) after you submit it. 

(b)

	You agree to assume the risks, including the risk that the market price of the Shares may change, related to delays described in paragraph 10(a): 

(1)

	Between the time you ask for any Shares to be sold and the time your Shares are actually sold; and 

(2)

	Between the time you ask for stock certificates to be delivered to you or your broker and the time the certificates are delivered. 

11.	Applicable Law 

You understand and agree that: 

(a)

	The terms and conditions of this Restricted Stock grant (including any Violation and the consequences of any Violation) and all determinations made under the Restricted Stock Grant Agreement, the Plan, and these Terms and Conditions will be interpreted under the laws of the Commonwealth of Pennsylvania, without regard to its conflict of laws rule; 

(b)

	Any dispute about any of the Promises (described in paragraph 7(b)), if not resolved by agreement between you and Cigna, will be resolved exclusively in a federal or state court in the Commonwealth of Pennsylvania where venue is appropriate and that has subject matter jurisdiction over the dispute (collectively, “Pennsylvania Courts”); 

(c)

	Pennsylvania is a convenient forum for resolving any dispute about the Promises; and 

(d)

	You and Cigna consent to the exercise of personal jurisdiction over the parties by a Pennsylvania Court in any dispute related to the Promises. 

12.	Arbitration 

You agree and understand that: 

(a)

	Any dispute over any of the terms and conditions that apply to this Restricted Stock grant will be resolved exclusively under the Cigna Employment Dispute Arbitration Policy and its Rules and Procedures as may be in effect when the dispute arises; 

(b)

	You are waiving your right to have those disputes decided by a judge or jury in a court of law, and instead you are agreeing to submit those disputes exclusively to mandatory and binding final arbitration; 

(c)

	While you or Cigna may seek emergency, temporary or permanent injunctive relief from a court in accordance with applicable law, after the court has issued a decision about that relief, you and Cigna will submit the dispute to final and binding arbitration under the Cigna Employment Dispute Arbitration Policy; and 

(d)

	This arbitration provision will not apply to any dispute related to the Promises. 

13.	Miscellaneous 

(a)

	If a court of competent jurisdiction determines that any provision of these Terms and Conditions is unenforceable as written, that provision will be enforceable to the maximum extent permitted by law and will be reformed by the court to make the provision enforceable in accordance with Cigna’s intent and applicable law. 

(b)

	Cigna’s failure to enforce any provision of this Restricted Stock grant will not be interpreted as a waiver of its right to enforce that provision in the future. 

6

14.	Acceptance 

If you disagree with any of these Terms and Conditions, including those in paragraphs 7, 8 and 9, YOU MUST NOT ACCEPT THE RESTRICTED STOCK GRANT. If you sign the Restricted Stock grant, or acknowledge your acceptance electronically or otherwise, you will be: 

(a)

	Agreeing to all the terms and conditions of the Restricted Stock grant including the Promises in paragraph 7(b); 

(b)

	Warranting and representing to Cigna that you are, and will remain, in full compliance with those terms and conditions; and 

(c)

	Authorizing Cigna to recover the Payment described in paragraph 8 and seek an injunction described in paragraph 9, if you engage in a Violation. 

______ __, ____ RSG Terms and Conditions

7Exhibit 10.1-Employment Agreement

Exhibit 10.1

February 21, 2012

Jorge Titinger
5674 Portrush Court
San Jose, California  95138

Re:    Employment Terms

Dear Jorge:

Silicon Graphics International Corp. (the “Company”), is pleased to offer you the position of President and Chief Executive Officer (the “CEO”), on the following terms.  Your employment shall commence on February 27, 2012 (the “Start Date”).

		
	1)
	POSITION.  You will serve in an executive capacity and shall perform the duties of CEO as commonly associated with this position, as specified in the Bylaws of the Company, and as required by the Board of Directors of the Company (the “Board”).  You will report to the Board.  Of course, the Company may change your position, duties, and work location from time to time in its discretion, subject to the terms of this offer letter agreement.  

		
	2)
	COMPENSATION.  

		
	a)
	Base Salary.  Your initial annual base salary will be $500,000, less standard payroll deductions and withholdings.  You will be paid bi-weekly in accordance with Company practice and policy.  

		
	b)
	Initial Performance Bonus.  You are eligible to earn a target initial performance bonus of $166,666.67.  Your initial participation will be based upon your performance against organizational milestones (“Milestone Targets”), determined by your input with the Compensation Committee and approved by the Board.  Any such bonus payment shall be deemed earned upon fulfillment of Milestone Targets and your continued employment through the bonus payment date, and shall be paid within a reasonable period of time, but not later than 45 days, after the end of the 2012 fiscal year.  The Compensation Committee of the Board will determine in its sole discretion whether the performance targets have been achieved, whether you have earned a bonus, and the amount of any earned bonus.  

		
	c)
	Performance Bonus.  You are eligible to earn a quarterly target bonus of $125,000 beginning fiscal year 2013, based upon the Company's performance with respect to applicable performance targets (“Targets”) as recommended by management and approved by the Compensation Committee of the Board.  Any such bonus payment shall be deemed earned upon the fulfillment of targets and your continued employment through the bonus measurement date, and shall be paid within a reasonable period of time, but not later than 45 days, after the end of the quarter.  The Compensation Committee of the Board will determine in its sole discretion whether the performance targets have been achieved, whether you have earned a bonus, and the amount of any earned bonus.  

		
	d)
	Review of Compensation.  Your base salary and bonus eligibility will be reviewed on an annual or more frequent basis by the Compensation Committee and are subject to change in the discretion of the Compensation Committee, subject to the terms of this offer letter agreement.   

		
	3)
	EQUITY AWARD.

		
	a)
	Equity Grants.  Subject to Compensation Committee approval, the Company will issue you an option (the “Option Award”) to purchase 325,000 shares of the Company's common stock pursuant to the Company's 2006 New Recruit Equity Incentive Plan (the “Plan”) at an exercise price equal to the fair market value of the stock as of the date of grant.  As standard practice, the date of grant is scheduled for the first business day of the 

month following your start date (March 1, 2012 in your case).  In addition, subject to Compensation Committee approval, the Company will grant you the right to receive 325,000 shares of the Company's common stock pursuant to the Plan (the “Restricted Stock Unit Award”).
		
	b)
	Vesting Schedule.  The Option Award will be subject to a four-year vesting period that requires your continuous service to the Company as an employee or consultant (as defined in the Plan and the Stock Option Award Agreement), with 25% of the Option Award vesting upon completion of your first year of continuous service as an employee or consultant, and an additional 2.0833% of the Option Award vesting for each full month of your continuous service as an employee or consultant following such first year.  The Restricted Stock Unit Award will be subject to a four-year vesting period that requires your continuous service to the Company as an employee or consultant (as defined in the Plan and the Stock Unit Award Agreement), with 25% vesting upon completion of the first year of continuous service as an employee or consultant, and an additional 6.25% of such Restricted Stock Unit Award vesting for each 3 months of continuous service as an employee or consultant after such first year.

		
	c)
	Signing Bonus Grant.  In addition to the new hire equity grants described above, subject to Compensation Committee approval, the Company will grant you the right to receive 15,000 shares of the Company's common stock pursuant to the Plan (the “Bonus Restricted Stock Unit Award”).  The Bonus Restricted Stock Unit Award will be subject to a one-year vesting period that requires your continuous service to the Company as an employee or consultant (as defined in the Plan and the Stock Unit Award Agreement), with 100% vesting upon completion of the first year of continuous service as an employee or consultant.

		
	d)
	Governing Documents.  The Option Award will be governed in full by the terms and conditions of the Plan and your individual Option Award Agreement; the Restricted Stock Unit Award will be governed in full by the terms and conditions of the Plan and the Stock Unit Award Agreement. 

		
	4)
	EMPLOYEE BENEFITS.  You will be eligible to participate in the Company's standard employee benefit plans provided by the Company to its executive employees generally in accordance with the terms and conditions of the plans and applicable policies that may be in effect from time to time, and including but not limited to group health insurance coverage, disability insurance, life insurance, ESPP, 401(k) Plan, and paid time off and paid holidays.  You will be eligible for reimbursement of your legitimate and documented business expenses incurred in connection with your employment, pursuant to the Company's standard reimbursement expense policy and practices.  The Company may modify its benefits programs and policies from time to time in its discretion.  

		
	5)
	PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT.  As a condition of your employment, you are required to sign and abide by the Company's Proprietary Information and Inventions Agreement (the “Non-Disclosure Agreement”), attached hereto as Exhibit A.  

		
	6)
	SERVICE AS EMPLOYEE; OUTSIDE ACTIVITIES.  

		
	a)
	Location and Duties.  You will work at the Company's corporate facility currently located in Fremont, California, subject to necessary business travel.  During your employment with the Company, you will devote your best efforts and substantially all of your business time and attention (except for vacation periods and reasonable periods of illness or other incapacity permitted by the Company's general employment policies) to the business of the Company.    

		
	b)
	Company Policies.  Your employment relationship with the Company shall also be governed by the general employment policies and practices of the Company, including but not limited to the policies contained in the Company's Employee Handbook (except that if the terms of this letter differ from or are in conflict with the Company's general employment policies or practices, this letter will control), and you will be required to abide by such general employment policies and practices of the Company.

		
	c)
	Other Activities.  Throughout your employment with the Company, you may engage in civic and not-for-profit activities so long as such activities do not interfere with the performance of your duties hereunder or present a conflict of interest with the Company.  Subject to the restrictions set forth herein and only with the prior written consent of the Board, you may serve as a director of other corporations and may devote a reasonable 

amount of your time to other types of business or public activities not expressly mentioned in this paragraph.  
		
	d)
	Conflict of Interest.  During your employment by the Company, except on behalf of the Company, you will not directly or indirectly serve as an officer, director, stockholder, employee, partner, proprietor, investor, joint venturer, associate, representative or consultant for or on behalf of any other person, corporation, firm, partnership or other entity whatsoever known by you to compete with the Company (or is planning or preparing to compete with the Company), anywhere in the world, in any line of business engaged in (or planned to be engaged in) by the Company; provided, however, that you may purchase or otherwise acquire up to (but not more than) one percent (1%) of any class of securities of any enterprise (but without participating in the activities of such enterprise) if such securities are listed on any national or regional securities exchange.

		
	7)
	AT-WILL EMPLOYMENT RELATIONSHIP.  Your employment relationship with the Company is at-will.  Accordingly, both you and the Company may terminate the employment relationship at any time, with or without Cause (as defined below), and with or without advance notice.  However, if your employment is terminated without Cause by the Company or you resign for a Good Reason, you will be entitled to the severance benefit defined herein. 

		
	8)
	DEFINITIONS.

		
	a)
	Definition of “Cause.”  For purposes of this offer letter agreement, “Cause” is defined as one or more of the following events:  (i) the conviction for a felony or plea of no contest, or any misdemeanor involving moral turpitude; (ii) the commission of any other act or omission involving fraud or intentional deceit with respect to the Company or any of its affiliates or any of their directors, stockholders, partners or members; (iii) any act or omission involving dishonesty that causes material injury to the Company or any of its affiliates or any of their directors, stockholders, partners or members; (iv) gross negligence with respect to the Company or any of its subsidiaries that causes material harm to them; (v) willful misconduct with respect to the Company or any of its subsidiaries that causes material harm to them; (vi) any other material breach of your contractual, statutory, or common law obligations to the Company that causes material harm to it; provided, however, that, it shall only be deemed Cause pursuant to clause (vi)  if you are given written notice describing the basis of Cause and, if the event is reasonably susceptible of cure, you fail to cure within thirty (30) days.

		
	b)
	Definition of “Good Reason.”  For purposes of this offer letter agreement, “Good Reason” is defined as one or more of the following conditions that occur without your written consent:  (i) the assignment to you, or the removal from you, of any duties or responsibilities that in the aggregate results in the material diminution of your authority, duties or responsibilities as CEO, including a Change in Control that results in your no longer serving as the CEO; (ii) a reduction by the Company of your base salary other than reductions in base salary that apply broadly to all employees of the Company; (iii) the Company's material breach of its obligations to you under this offer letter agreement; (iv) your office relocation to a location more than fifty miles from your then present location; or (v) a failure or refusal of a successor to the Company to assume Company's obligations under this Agreement; provided however that, it shall only be deemed Good Reason pursuant to the foregoing definition if (x) the Company is given written notice from you within ninety (90) days following the last occurrence of a condition that you consider to constitute Good Reason describing the condition and fails to remedy such condition within thirty (30) days following such written notice, and (y) you resign from employment within ninety (90) days following the end of the period within which the Company was entitled to remedy the condition constituting Good Reason but failed to do so.

		
	c)
	Definition of “Change in Control.”  For purposes of this offer letter agreement, “Change in Control” means the occurrence, in a single transaction or in a series of related transactions, of either of the following events:  

		
	i)
	There is consummated (A) a merger, consolidation or similar transaction involving (directly or indirectly) the Company or (B) a tender offer or exchange offer addressed to the stockholders of the Company and, in either event, immediately after the consummation of such merger, consolidation or similar transaction or such tender or exchange offer, the stockholders of the Company immediately prior thereto do not own, directly or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%) of the combined outstanding voting power of the surviving entity in such merger, consolidation or similar 

transaction or (B) more than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their ownership of the outstanding voting securities of the Company immediately prior to such transaction; or 
		
	ii)
	There is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its subsidiaries to an entity, more than fifty percent (50%) of the combined voting power of the voting securities of which are owned by stockholders of the Company in substantially the same proportions as their ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition. 

The term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company.
		
	9)
	CHANGE IN CONTROL SEVERANCE BENEFITS.  If, within 12 months following a Change in Control, your employment is terminated by the Company without Cause, or by you for Good Reason; and you sign, date, return to the Company and allow to become effective a release of all claims in a form satisfactory to the Company in its sole discretion (the “Release”), in a form attached hereto as Exhibit B, then in lieu of any Severance Benefits set forth in Section 10 herein, you shall be entitled to receive the following severance benefits (the “Change in Control Severance Benefits”); provided that you must execute and return the release on or before the date specified by the Company in the prescribed form (the “Release Deadline”).  The Release Deadline will in no event be later than 50 days after your Separation.  If you fail to return the release on or before the Release Deadline, or if you revoke the release, then you will not be entitled to the benefits described in this Section 10 or Section 11.  The severance payments will commence within 60 days after your Separation and, once they commence, will include any unpaid amounts accrued from the date of your Separation.  However, if the 60-day period described in the preceding sentence spans two calendar years, then the payments will in any event begin in the second calendar year.

		
	a)
	Accelerated Vesting.  All unvested stock options and restricted stock units referred to herein and any subsequent grants of stock options, restricted stock units or any other equity awards granted under current or future plans shall become fully vested upon the closing of a Change in Control of the Company; 

		
	b)
	Severance Pay.  Upon the closing of a Change in Control of the Company, you will be eligible to receive severance pay in the total amount equal to the sum of (i) twelve (12) months of your base salary in effect as of the employment termination date (ii) the full amount of your annual performance bonus at target, and (iii) the prorated amount of your annual performance bonus at target for the year in which the termination occurred.  The severance pay will be subject to required payroll deductions and withholdings, and will be paid in twenty-six (26) equal installments over a period of twelve (12) months, with such payments made on the Company's normal payroll schedule; and 

		
	c)
	COBRA Benefits.  If you timely elect and continue to remain eligible for continued group health insurance coverage under federal COBRA law or, if applicable, state insurance laws (collectively, “COBRA”), the Company will pay your COBRA premiums sufficient to continue your group health insurance coverage at the same level in effect as of your employment termination date (including dependent coverage, if applicable) for twelve (12) months after the employment termination date; provided that, the Company's obligation to pay your COBRA premiums will cease earlier if you become eligible for group health insurance coverage through a new employer and you must provide prompt written notice to the Company if you become eligible for group health insurance coverage through a new employer within twelve (12) months after your employment termination date.   Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it cannot provide the foregoing benefit without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Services Act), the Company shall instead provide you a taxable monthly payment in an amount equal to the monthly COBRA premium that you would otherwise be required to pay to continue your group health coverage in effect from the date of your termination of employment, which payments shall be made regardless of whether you elect COBRA continuation coverage and shall end on the 

earlier of (x) the date on which you obtain other employment and (y) twelve (12) months after your employment termination date.
		
	10)
	SEVERANCE BENEFITS.  If, at any time other than during the 12 month period following a Change in Control, your employment is terminated by the Company without Cause, or by you for Good Reason; and you sign, date, return to the Company and allow to become effective a release of all claims in a form satisfactory to the Company in its sole discretion (the “Release”);, then you shall be entitled to receive the following severance benefits (the “Severance Benefits”); provided that you must execute and return the release on or before the Release Deadline The severance payments will commence within 60 days after your Separation and, once they commence, will include any unpaid amounts accrued from the date of your Separation.  However, if the 60-day period described in the preceding sentence spans two calendar years, then the payments will in any event begin in the second calendar year.

		
	a)
	Accelerated Vesting.  All unvested stock options and restricted stock units referred to herein and any subsequent grants of stock options, restricted stock units or any other equity awards granted under current or future plans shall accelerate in such amount equal to the number of shares that would vest over an additional twenty-four (24) month period as if you had continued to be an employee of the Company for an additional twenty-four (24) months following your termination; 

		
	b)
	Severance Pay.  You will be eligible to receive severance pay in the total amount equal to the sum of (i) twelve (12) months of your base salary in effect as of the employment termination date, (ii) the full amount of your annual performance bonus at target, and (iii) the prorated amount of your annual performance bonus at target for the year in which the termination occurred.  The severance pay will be subject to required payroll deductions and withholdings, and will be paid in twenty-six (26) equal installments over a period of twelve (12) months, with such payments made on the Company's normal payroll schedule; and

		
	c)
	COBRA Benefits.  If you timely elect and continue to remain eligible for COBRA, the Company will pay your COBRA premiums sufficient to continue your group health insurance coverage at the same level in effect as of your employment termination date (including dependent coverage, if applicable) for twelve (12) months after the employment termination date; provided that, the Company's obligation to pay your COBRA premiums will cease earlier if you become eligible for group health insurance coverage through a new employer and you must provide prompt written notice to the Board if you become eligible for group health insurance coverage through a new employer within twelve (12)  months after your employment termination date.  Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it cannot provide the foregoing benefit without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Services Act), the Company shall instead provide you a taxable monthly payment in an amount equal to the monthly COBRA premium that you would otherwise be required to pay to continue your group health coverage in effect from the date of your termination of employment, which payments shall be made regardless of whether you elect COBRA continuation coverage and shall end on the earlier of (x) the date on which you obtain other employment and (y) twelve (12) months after your employment termination date.

		
	11)
	CONDITIONS TO ELIGIBILITY TO SEVERANCE BENEFITS OR CHANGE IN CONTROL SEVERANCE BENEFITS.  Notwithstanding the foregoing, you will not be eligible for the Severance Benefits or the Change in Control Severance Benefits if: (A) your employment is terminated for Cause, or if you resign for any reason that does not qualify as Good Reason; or (B) in the event that you materially breach the Non-Disclosure Agreement, the Release of claims, or any other obligations you owe to the Company after termination of your employment (including but not limited to the provisions of the Non-Disclosure Agreement), and the Company's obligation to provide the Severance Benefits or the Change in Control Benefits (or to continue to provide such benefits) will cease immediately and in full as of the date of your breach.

		
	12)
	PROCEDURE FOR “CAUSE” FINDING.  

		
	a)
	You may only be terminated for Cause if a majority of the Board then in office determines that grounds for Cause exists.  In the event of such determination, the Company will give you notice of the finding of Cause with reasonable specificity, and will provide you with a reasonable opportunity to meet with the Board to 

refute the finding.
		
	i)
	If you elect to appear before the Board to dispute the finding, the Board will meet with you.  Following such meeting, the Board shall reconsider its initial finding and the decision of a majority of the Board then in office will be required to confirm the determination that grounds for Cause exist.

		
	ii)
	If you decline to appear before the Board to dispute the finding, then the initial action by the Board shall constitute the determination to terminate you for cause.

		
	b)
	Subsequent to a Change in Control, the procedural requirements of this paragraph shall apply, except that the findings of the Board must be approved by not less than two-thirds of the Directors then in office.

		
	13)
	DEFERRED COMPENSATION.  Notwithstanding anything to the contrary herein, the following provisions apply to the extent severance benefits provided herein are subject to Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the regulations and other guidance thereunder and any state law of similar effect (collectively, “Section 409A”).  Severance benefits shall not commence until you have a “separation from service” for purposes of Section 409A.   Each installment of  severance benefits is a separate “payment” for purposes of Treas. Reg. Section 1.409A-2(b)(2)(i), and the severance benefits are intended to satisfy the exemptions from application of Section 409A provided under Treasury Regulations Sections 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9).  However, if such exemptions are not available and you are, upon separation from service, a “specified employee” for purposes of Section 409A, then, solely to the extent necessary to avoid adverse personal tax consequences under Section 409A, the timing of the severance benefits payments shall be delayed until the earlier of (i) six (6) months and one day after your separation from service and (ii) your death.  Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or in installments) in the absence of this paragraph shall be paid to Employee or Employee's beneficiary in one lump sum (without interest).  Any termination of Employee's employment is intended to constitute a “separation from service” and will be determined consistent with the rules relating to a “separation from service” as such term is defined in Treasury Regulation Section 1.409A-1.  It is intended that each installment of the payments provided hereunder constitute separate “payments” for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i).  To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision will be read in such a manner so that all payments hereunder comply with Section 409A of the Code.  Except as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit under this Agreement is determined to be subject to Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses), in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in which you incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit.

		
	14)
	EXCISE TAX.  

		
	a)
	Reduced Amount.  Anything in this agreement to the contrary notwithstanding, if any payment or benefit that you would receive pursuant to this offer letter agreement or otherwise (“Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall be equal to the Reduced Amount (defined below).  The “Reduced Amount” shall be either (y) the largest portion of the Payment that would result in no portion of the Payment (after reduction) being subject to the Excise Tax, or (z) the entire Payment, whichever amount after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate, net of the maximum reduction in federal income taxes which could be obtained from a deduction of such state and local taxes), results in your receipt, on an after-tax basis, of the greater economic benefit.

		
	b)
	Order of Reduction.  Any reduction in the Payment that is required shall occur in such manner as will provide you with the greatest economic benefit.  If more than one manner of reduction necessary to arrive at the 

Reduced Amount yields the greatest economic benefit, then payments and benefits shall be reduced pro rata.  Any reduction shall be made in the following manner:  first a pro rata reduction of (i) cash payments subject to Section 409A of the Code as deferred compensation and (ii) cash payments not subject to Section 409A of the Code, and second a pro rata cancellation of (i) equity-based compensation subject to Section 409A of the Code as deferred compensation and (ii) equity-based compensation not subject to Section 409A of the Code.  Reduction in either cash payments or equity compensation benefits shall be made prorata between and among benefits which are subject to Section 409A of the Code and benefits which are exempt from Section 409A of the Code. 
		
	c)
	Accounting Firm.  The accounting firm engaged by the Company for general audit purposes as of the day prior to the effective date of the Payment Event shall perform the foregoing calculations.  If the accounting firm so engaged by the Company is serving as accountant or auditor for the individual, entity or group effecting the Payment Event, a nationally recognized accounting firm appointed by the Board and reasonably approved by you shall make the determinations required hereunder.  The Company shall bear all expenses with respect to the determinations by such accounting firm required to be made hereunder.

		
	d)
	Calculations.  The accounting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation, to the Company and you within fifteen (15) calendar days after the date on which your right to a Payment is triggered (if requested at that time by the Company or you) or such other time or times as requested by the Company or you.  If the accounting firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the Reduced Amount, it shall furnish the Company and you with an opinion reasonably acceptable to you that no Excise Tax will be imposed with respect to such Payment.  The Company shall be entitled to rely upon the accounting firm's determinations, which shall be final and binding.

		
	15)
	DISPUTE RESOLUTION.

		
	a)
	Arbitration Agreement.  To ensure the rapid and economical resolution of disputes that may arise in connection with your employment, you and the Company agree that any and all disputes, claims, or causes of action, in law or equity, arising from or relating to the enforcement, breach, performance, execution, or interpretation of this agreement, your employment, or the termination of your employment, shall be resolved, to the fullest extent permitted by law, by final, binding and confidential arbitration in San Francisco, California conducted before a single neutral arbitrator by Judicial Arbitration and Mediation Services, Inc. (“JAMS”) or its successor, under the then applicable JAMS rules for the resolution of employment disputes.  By agreeing to this arbitration procedure, both you and the Company waive the right to resolve any such dispute through a trial by jury or judge or by administrative proceeding. 

		
	b)
	Arbitrator Authority.  The arbitrator shall:  (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision including the arbitrator's essential findings and conclusions and a statement of the award.  All claims, disputes, or causes of action under this Agreement, whether by you or the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor brought in any private attorney general capacity or proceeding, nor joined or consolidated with the claims of any other person or entity.  The arbitrator may not consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding.

		
	c)
	Fees and Injunctive Relief.  The Company shall pay all of JAMS' arbitration fees.  The parties agree that the arbitrator shall award reasonable attorneys' fees and costs to the prevailing party in any action brought hereunder to the extent that such an award would be consistent with applicable law.  The arbitrator shall have discretion to determine the prevailing party in an arbitration where multiple claims may be at issue.  Nothing in this letter agreement shall prevent either you or the Company from obtaining injunctive relief in court if necessary to prevent irreparable harm pending the conclusion of any arbitration.

		
	d)
	Federal Arbitration Act.  This agreement is made under the provisions of the Federal Arbitration Act (9 

U.S.C., Sections 1-14) (“FAA”) and will be construed and governed accordingly.  It is the parties' intention that both the procedural and the substantive provisions of the FAA shall apply.

		
	16)
	MISCELLANEOUS.  

		
	a)
	General Provisions.  This letter, including the attached Non-Disclosure Agreement, constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to the subject matter hereof.  It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other agreements, promises, warranties or representations concerning its subject matter.  Changes in your employment terms, other than those expressly reserved herein to the Company's discretion, only can be made in a writing signed by a duly-authorized member of the Company and you.  This letter agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns.  If any provision of this letter agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this letter agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible under applicable law.  This letter agreement shall be construed and enforced in accordance with the laws of the State of California without regard to conflicts of law principles.  Any ambiguity in this letter agreement shall not be construed against either party as the drafter.  Any waiver of a breach of this letter agreement, or rights hereunder, shall be in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder.  This letter agreement may be executed in counterparts which shall be deemed to be part of one original, and facsimile signatures shall be equivalent to original signatures.

		
	b)
	Legal Right to Work.  As required by law, this offer is subject to satisfactory proof of your right to work in the United States.

		
	17)
	APPLICABLE LAW.  This agreement will be governed by the laws of the State of California.

		
	18)
	ACCEPTANCE.  Please sign this letter and the attached Non-Disclosure Agreement and return them to me as soon as possible to accept employment with the Company on the terms set forth herein.  We are very excited about having you join us as an employee and look forward to working with you.

Sincerely,

Silicon Graphics International, Corp.

By:  /s/ Gary Griffiths                                    
        Gary Griffiths
        Chairman of the Corporate Governance and Nominating Committee of the Board of Directors
    

2/20/12        
Date

Understood and Agreed:

 /s/ Jorge Titinger                                    
Jorge Titinger

2/21/12                                            
Date

Exhibit A - Non-Disclosure Agreement

EXHIBIT A

NON-DISCLOSURE AGREEMENT

SILICON GRAPHICS INTERNATIONAL, CORP.

EMPLOYEE PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT

In consideration of my employment by Silicon Graphics International, Corp., a Delaware corporation (the “Company”), I hereby agree to the following with respect to my use and development of information and technology of the Company, as more fully set out below.  
1.Proprietary Information.  
(a)Confidential Restrictions.  I agree to hold in strict confidence and in trust for the sole benefit of the Company all Proprietary Information (as defined below) that I may have access to during the course of my employment with the Company and will not disclose any Proprietary Information, directly or indirectly, to anyone outside of the Company, or use, copy, publish, summarize, or remove from Company premises such information (or remove from the premises any other property of the Company) except: (i) during my employment as authorized by Company policy and to the extent necessary to carry out my responsibilities as an employee of the Company, or (ii) after termination of my employment, as specifically authorized in writing by the President of the Company.  I further understand that the publication of any Proprietary Information through literature or speeches must be approved in advance in writing by the President of the Company.  
(b)Proprietary Information.  “Proprietary Information” shall mean and all confidential knowledge, data or information related to the Company's business or its actual or demonstrably anticipated research or development, including without limitation: (i) trade secrets, inventions, ideas, processes, computer source and object code, data, formulae, programs, other works of authorship, know-how, improvements, discoveries, developments, designs, and techniques; (ii) information regarding products, services, plans for research and development, marketing and business plans, budgets, financial statements, contracts, prices, suppliers, and customers; (iii) information regarding the skills and compensation of the Company's employees, contractors, and any other service providers of the Company; and (iv) the existence of any business discussions, negotiations, or agreements between the Company and any third party.  
(c)Exclusions.  Proprietary Information shall not include: (i) information which is or becomes publicly known through lawful means; (ii) information which was rightfully in my possession or part of my general knowledge prior to my employment by the Company; or (iii) information which is disclosed to me without confidential or proprietary restriction by a third party who rightfully possesses the information (without confidential or proprietary restriction) and did not learn of it, directly or indirectly, from the Company.  
(d)Third Party Information.  I recognize that the Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company's part to maintain the confidentiality of such information and to use it only for certain limited purposes.  I agree that I owe the Company and such third parties, during the term of my employment and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm, or corporation (except as necessary in carrying out my work for the Company consistent with the Company's agreement with such third party) or to use it for the benefit of anyone other than for the Company or such third party (consistent with the Company's agreement with such third party) without the express written authorization of the President of the Company.  
(e)No Interference with Business.  In order to protect the Company's and its goodwill, I agree that: (i) during the term of my employment by the Company, I will not, without the Company's express written consent, engage in any employment or business activity that is competitive with, or would otherwise conflict with my employment by, the Company, and (ii) for the period of my employment by the Company and for one (l) year thereafter, I will not, either directly or indirectly, solicit, induce or encourage or attempt to solicit, induce or encourage any employee, independent contractor, or consultant of the Company to terminate his, her or its relationship with the Company in order to become an employee, consultant, or independent contractor to or for any other person or entity.
2.Inventions.  
(a)Defined; Statutory Notice.  I understand that during the term of my employment, there are certain restrictions on my development of technology, ideas, and inventions, referred to in this Agreement as “Invention Ideas.” 

The term Invention Ideas means any and all ideas, processes, trademarks, service marks, inventions, technology, computer programs, original works of authorship, designs, formulas, discoveries, patents, copyrights, and all improvements, rights, and claims related to the foregoing that are conceived, developed, or reduced to practice by me alone or with others except to the extent that California Labor Code Section 2870 lawfully prohibits the assignment of rights in such ideas, processes, inventions, etc.  I understand that Section 2870(a) provides: 
Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer's equipment, supplies, facilities, or trade secret information except for those inventions that either: 
(1)   Relate at the time of conception or reduction to practice of the invention to the employer's business, or actual or demonstrably anticipated research or development of the employer.  
(2)  Result from any work performed by the employee for the employer.  
(b)Records of Invention Ideas.  I agree to maintain adequate and current written records on the development of all Invention Ideas and to disclose promptly to the Company all Invention Ideas and relevant records, which records will remain the sole property of the Company.  I further agree that all information and records pertaining to any idea, process, trademark, service mark, invention, technology, computer program, original work of authorship, design, formula, discovery, patent, or copyright that I do not believe to be an Invention Idea, but is conceived, developed, or reduced to practice by me (alone or with others) during my period of employment shall be promptly disclosed to the Company (such disclosure to be received in confidence).  The Company shall examine such information to determine if in fact the idea, process, or invention, etc., is an Invention Idea subject to this Agreement.  
(c)Assignment.  I hereby assign, and agree to assign in the future, to the Company, without further consideration, my entire right, title, and interest (throughout the United States and in all foreign countries), free and clear of all liens and encumbrances, in and to each Invention Idea, which shall be the sole property of the Company, whether or not patentable.  In the event any Invention Idea shall be deemed by the Company to be patentable or otherwise registrable, I will assist the Company (at its expense) in obtaining letters patent or other applicable registrations thereon and I will execute all documents and do all other things (including testifying at the Company's expense) necessary or proper to obtain letters patent or other applicable registrations thereon and to vest the Company with full title thereto.  Should the Company be unable to secure my signature on any document necessary to apply for, prosecute, obtain, or enforce any patent, copyright, or other right or protection relating to any Invention Idea, whether due to my mental or physical incapacity or any other cause, I hereby irrevocably designate and appoint the Company and each of its duly authorized officers and agents as my agent and attorney-in-fact, to act for and in my behalf and stead, to execute and file any such document, and to do all other lawfully permitted acts to further the prosecution, issuance, and enforcement of patents, copyrights, or other rights or protections with the same force and effect as if executed and delivered by me.  
(d)Excluded Inventions.  Except as disclosed in Exhibit A, there are no ideas, processes, trademarks, service marks, inventions, technology, computer programs, original works of authorship, designs, formulas, discoveries, patents, copyrights, or improvements to the foregoing that I wish to exclude from the operation of this Agreement (“Excluded Inventions”).  If no Excluded Inventions are listed in Exhibit A, I warrant that there are no Excluded Inventions.  I agree that I will not incorporate, or permit to be incorporated, Excluded Inventions in any Invention Idea without the Company's prior written consent. If, in the course of my employment with the Company, I incorporate an Excluded Invention into a Company process, machine or other work, I hereby grant the Company a non-exclusive, perpetual, fully-paid and royalty-free, irrevocable and worldwide license, with rights to sublicense through multiple levels of sublicensees, to reproduce, make derivative works of, distribute, publicly perform, and publicly display in any form or medium, whether now known or later developed, make, have made, use, sell, import, offer for sale, and exercise any and all present or future rights in, such Excluded Invention.  
(e)Post-Termination Period. the one (1) year period after my employment ends, I will promptly and fully disclose to the Company in writing: (i) all inventions authored, conceived, or reduced to practice by me, either alone or with others, including any that might be covered under California Labor Code Section 2870, and (ii) all patent 

applications filed by me or in which I am named as an inventor or co-inventor.  In addition, I agree to assign in the future any idea, process, trademark, service mark, invention, technology, computer program, original work of authorship, design, formula, discovery, patent, copyright, or any improvement, rights, or claims related to the foregoing which are conceived, developedor reduced to practice at any time (including after my employment with the Company ends) to the extent any such item is based upon any Invention Ideas or portions thereof.
I understand that nothing in this Agreement is intended to expand the scope of protection provided me by Sections 2870 through 2872 of the California Labor Code.  
3.Former or Conflicting Obligations.  During my employment with the Company, I will not disclose to the Company, or use, or induce the Company to use, any proprietary information or trade secrets of others.  I represent that my performance of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by me in confidence or in trust prior to my employment by the Company.  I certify that I have no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, or that would preclude me from complying with the provisions hereof.  I further represent that my employment by Company does not and will not breach any agreement with any former employer, including any noncompete agreement.
4.Government Contracts.  I understand that the Company has or may enter into contracts with the government under which certain intellectual property rights will be required to be protected, assigned, licensed, or otherwise transferred and I hereby agree to execute such other documents and agreements as are necessary to enable the Company to meet its obligations under any such government contracts.  
5.Termination.  I hereby acknowledge and agree that all personal property, including, without limitation, all books, manuals, records, models, drawings, reports, notes, contracts, lists, blueprints, and other documents or materials or copies thereof, Proprietary Information, and equipment furnished to or prepared by me in the course of or incident to my employment, belong to the Company and will be promptly returned to the Company upon termination of my employment with the Company.  Following my termination, I will not retain any written or other tangible material containing any Proprietary Information or information pertaining to any Invention Idea.  I understand that my obligations contained herein will survive the termination of my employment.  In the event of termination of my employment, I agree to sign and deliver to the Company a Termination Certificate in the form attached hereto as Exhibit B.  I further agree that I will not copy, delete, or alter any information contained upon my Company computer or Company equipment before I return it to the Company.  In addition, if I have used any personal computer, server, or e-mail system to receive, store, review, prepare or transmit any Company information, including but not limited to, Proprietary Information, I agree to provide the Company with a computer-useable copy of all such Proprietary Information and then permanently delete and expunge such Proprietary Information from those systems; and I agree to provide the Company access to my system as reasonably requested to verify that the necessary copying and/or deletion is completed.  I further agree that any property situated on the Company's premises and owned by the Company is subject to inspection by the Company's personnel at any time with or without further notice or consent.  Prior to the termination of my employment or promptly after termination of my employment, I will cooperate with the Company in attending an exit interview.
6.Miscellaneous Provisions.  
(a)Assignment.  I agree that the Company may assign to another person or entity any of its rights under this Agreement, including, without limitation, any successor in interest to the Company or its business operations.  This Agreement shall be binding upon me and my heirs, executors, administrators, and successors, and shall inure to the benefit of the Company's successors and assigns.  
(b)Governing Law; Severability.  The validity, interpretation, enforceability, and performance of this Agreement shall be governed by and construed in accordance with the laws of the State of California.  If any provision of this Agreement, or application thereof to any person, place, or circumstance, shall be held by a court of competent jurisdiction to be invalid, unenforceable, or void, the remainder of this Agreement and such provisions as applied to other persons, places, and circumstances shall remain in full force and effect.  
(c)Application of this Agreement.  I hereby agree that my obligations set forth in Sections 1 and 2 hereof and the definitions of Proprietary Information and Invention Ideas contained therein shall be equally applicable to Proprietary Information and Invention Ideas relating to any work performed by me for the Company prior to the 

execution of this Agreement.  
(d)Notification of New Employer.  If I leave the employ of the Company, I consent to the notification of my new employer of my rights and obligations under this Agreement, by the Company providing a copy of this Agreement or otherwise.
(e)Employment.  I agree and understand that nothing in this Agreement shall give me any right to continued employment by the Company, and it will not interfere in any way with my right or the Company's right to terminate my employment at any time, with or without cause and with or without advance notice.
(f)Injunctive Relief. I acknowledge that, because my services are personal and unique and because I will have access to the Proprietary Information of the Company, any breach of this Agreement by me would cause irreparable injury to the Company for which monetary damages would not be an adequate remedy and, therefore, will entitle the Company to injunctive relief (including specific performance).  The rights and remedies provided to each party in this Agreement are cumulative and in addition to any other rights and remedies available to such party at law or in equity.
(g)Entire Agreement.  The terms of this Agreement are the final and entire expression of my agreement with respect to the subject matter hereof and supersede any prior or contemporaneous agreements or representations.  This Agreement only may be modified in a written agreement signed by both me and a duly authorized officer of the Company.  

Date: ______________________                     __________________________________
Signature 

             __________________________________
Printed Name

Exhibit A

Employee's Prior Inventions

Except as set forth below, there are no ideas, processes, trademarks, service marks, inventions, technology, computer programs, original works of authorship, designs, formulas, discoveries, patents, copyrights, or any claims, rights, or improvements to the foregoing that I wish to exclude from the operation of this Agreement: 

Exhibit B

TERMINATION CERTIFICATE CONCERNING
PROPRIETARY INFORMATION AND INVENTIONS

This is to certify that I have returned all personal property of the Company, including, without limitation, all books, manuals, records, models, drawings, reports, notes, contracts, lists, blueprints, and other documents and materials, Proprietary Information, and equipment furnished to or prepared by me in the course of or incident to my employment with the Company, and that I did not make or distribute any copies of the foregoing.  
I further certify that I have reviewed the Employee Proprietary Information and Inventions Agreement signed by me and that I have complied with and will continue to comply with all of its terms, including, without limitation, (i) the reporting of any invention, process, or idea, etc.  conceived or developed by me and covered by the Agreement and (ii) the preservation as confidential of all Proprietary Information pertaining to the Company.  This certificate in no way limits my responsibilities or the Company's rights under the Agreement.  

Date: ______________________                        _____________________________________
       Signature 

       _____________________________________
       Printed Name

 

EXHIBIT B

GENERAL RELEASE AGREEMENT

GENERAL RELEASE AGREEMENT

In consideration of the severance benefits (the “Severance”) offered to me by Silicon Graphics International Corp. (“SGI”) pursuant to my offer letter with SGI dated ______________ (“Offer Letter”) and in connection with the termination of my employment, I agree to the following general release (the “Release”).
1.On behalf of myself, my heirs, executors, administrators, successors, and assigns, I hereby fully and forever generally release and discharge SGI, its current, former and future parents, subsidiaries, affiliated companies, related entities, employee benefit plans, and their fiduciaries, predecessors, successors, officers, directors, shareholders, agents, employees and assigns (collectively, the “Company”) from any and all claims, causes of action, and liabilities up through the date of my execution of the Release.  The claims subject to this release include, but are not limited to, those relating to my employment with SGI and/or any predecessor to SGI and the termination of such employment.  All such claims (including related attorneys' fees and costs) are barred without regard to whether those claims are based on any alleged breach of a duty arising in statute, contract, or tort.  This expressly includes waiver and release of any rights and claims arising under any and all laws, rules, regulations, and ordinances, including, but not limited to: Title VII of the Civil Rights Act of 1964; the Older Workers Benefit Protection Act; the Americans With Disabilities Act; the Age Discrimination in Employment Act; the Fair Labor Standards Act; the National Labor Relations Act; the Family and Medical Leave Act; the Employee Retirement Income Security Act of 1974, as amended (“ERISA”); the Workers Adjustment and Retraining Notification Act; the California Fair Employment and Housing Act (if applicable); the provisions of the California Labor Code (if applicable); the Equal Pay Act of 1963; and any similar law of any other state or governmental entity.  The parties agree to apply California law in interpreting the Release.  Accordingly, I further waive any rights under Section 1542 of the Civil Code of the State of California or any similar state statute.  Section 1542 states: “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which, if known to him or her, must have materially affected his or her settlement with the debtor.”  This Release does not extend to, and has no effect upon, any benefits that have accrued, and to which I have become vested, under any employee benefit plan within the meaning of ERISA sponsored by the Company.   
2.In understanding the terms of the Release and my rights, I have been advised to consult with an attorney of my choice prior to executing the Release.  I understand that nothing in the Release shall prohibit me from exercising legal rights that are, as a matter of law, not subject to waiver such as: (a) my rights under applicable workers' compensation laws; (b) my right, if any, to seek unemployment benefits; (c) my right to indemnity under California Labor Code section 2802 or other applicable state-law right to indemnity; and (d) my right to file a charge or complaint with a government agency such as but not limited to the Equal Employment Opportunity Commission, the National Labor Relations Board, the Department of Labor, the California Department of Fair Employment and Housing, or other applicable state agency.  Moreover, you will continue to be indemnified for your actions taken while employed by the Company to the same extent as other then-current or former directors and officers of the Company under the Company's Certificate of Incorporation and Bylaws and the Director and Officer Indemnification Agreement between you and the Company, if any, and you will continue to be covered by the Company's directors and officers liability insurance policy as in effect from time to time to the same extent as other then-current or former directors and officers of the Company, each subject to the requirements of the laws of the State of Delaware.  To the fullest extent permitted by law, any dispute regarding the scope of this general release shall be resolved through binding arbitration pursuant to Section 9 below, and the arbitration provision set forth in my Offer Letter.
3.I understand and agree that SGI will not provide me with the Severance unless I execute the Release.  I also understand that I have received or will receive, regardless of the execution of the Release, all wages owed to me together with any accrued but unused vacation pay, less applicable withholdings and deductions, earned through my termination date. 
4.As part of my existing and continuing obligations to SGI, I have returned to SGI all SGI documents (and all copies thereof) and other SGI property that I have had in my possession at any time, including but not limited to SGI files, notes, drawings, records, business plans and forecasts, financial information, specification, computer-

recorded information, tangible property (including, but not limited to, computers, laptops, cell phone, pagers, etc.), credit cards, entry cards, identification badges and keys; and any materials of any kind which contain or embody any proprietary or confidential information of SGI (and all reproductions thereof).  I understand that, even if I did not sign the Release, I am still bound by any and all confidential/proprietary/trade secret information, non-disclosure and inventions assignment agreement(s) signed by me in connection with my employment with SGI, or with a predecessor or successor of SGI pursuant to the terms of such agreement(s). 
5.I represent and warrant that I am the sole owner of all claims relating to my employment with SGI and/or with any predecessor of SGI, and that I have not assigned or transferred any claims relating to my employment to any other person or entity. 
6.I agree to keep the Severance and the provisions of the Release confidential and not to reveal its contents to anyone except my lawyer, my spouse or other immediate family member, and/or my financial consultant, or as required by legal process or applicable law. 
7.I understand and agree that the Release shall not be construed at any time as an admission of liability or wrongdoing by either the Company or myself.
8.I agree that I will not make any negative or disparaging statements or comments, either as fact or as opinion, about the Company, its employees, officers, directors, shareholders, vendors, products or services, business, technologies, market position or performance. Nothing in this paragraph shall prohibit me from providing truthful information in response to a subpoena or other legal process.
9.Any controversy or any claim arising out of or relating to the interpretation, enforceability or breach of the Release shall be settled by arbitration in accordance with the arbitration provision set forth in my Offer Letter.  If for any reason the arbitration provision set forth in my Offer Letter is not enforceable, I agree to arbitration under the employment arbitration rules of the American Arbitration Association or any successor hereto.  The parties further agree that the arbitrator shall not be empowered to add to, subtract from, or modify, alter or amend the terms of the Release.  Any applicable arbitration rules or policies shall be interpreted in a manner so as to ensure their enforceability under applicable state or federal law. 
10.I agree that I have had at least twenty-one (21) calendar days in which to consider whether to execute the Release, no one hurried me into executing the Release during that period, and no one coerced me into executing the Release.  I understand that the offer of the Severance and the Release shall expire on the twenty-second (22nd) calendar day after my employment termination date if I have not accepted it by that time.  I further understand that SGI's obligations under the Release shall not become effective or enforceable until the eighth (8th) calendar day after the date I sign the Release provided that I have timely delivered it to SGI (the “Effective Date”) and that in the seven (7) day period following the date I deliver a signed copy of the Release to SGI I understand that I may revoke my acceptance of the Release.  I understand that the Severance will become available to me at such time after the Effective Date as specified in my Offer Letter.  
11.In executing the Release, I acknowledge that I have not relied upon any statement made by SGI, or any of its representatives or employees, with regard to the Release unless the representation is specifically included herein.  Furthermore, the Release contains our entire understanding regarding eligibility for and the payment of severance benefits and supersedes any or all prior representation and agreement regarding the subject matter of the Release.  However, the Release does not modify, amend or supersede written SGI agreements that are consistent with enforceable provisions of this Release such as my Offer Letter, proprietary information and invention assignment agreement, and any stock, stock option and/or stock purchase agreements between SGI and me.  Once effective and enforceable, this agreement can only be changed by another written agreement signed by me and an authorized representative of SGI.  
12.Should any provision of the Release be determined by an arbitrator, court of competent jurisdiction, or government agency to be wholly or partially invalid or unenforceable, the legality, validity and enforceability of the remaining parts, terms, or provisions are intended to remain in full force and effect. Specifically, should a court, arbitrator, or agency conclude that a particular claim may not be released as a matter of law, it is the intention of the parties that the general release and the waiver of unknown claims above shall otherwise remain effective to release 

any and all other claims.  I acknowledge that I have obtained sufficient information to intelligently exercise my own judgment regarding the terms of the Release before executing the Release. 

[Signature Page to General Release Agreement Follows]

EMPLOYEE'S ACCEPTANCE OF RELEASE
BEFORE SIGNING MY NAME TO THE RELEASE, I STATE THE FOLLOWING:  I HAVE READ THE RELEASE, I UNDERSTAND IT AND I KNOW THAT I AM GIVING UP IMPORTANT RIGHTS.  I HAVE OBTAINED SUFFICIENT INFORMATION TO INTELLIGENTLY EXERCISE MY OWN JUDGMENT. I HAVE BEEN ADVISED THAT I SHOULD CONSULT WITH AN ATTORNEY BEFORE SIGNING IT, AND I HAVE SIGNED THE RELEASE KNOWINGLY AND VOLUNTARILY.

Date delivered to employee ___________, ______.
Executed this ___________ day of ___________, ______.

____________________________________________________                
Employee Signature
____________________________________________________                    
Employee Name (Please Print)

[Signature Page to General Release Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]